Tirzepatide vs Semaglutide: How the Two Differ

Tirzepatide and semaglutide differ in the receptors they activate, the products available, and their clinical evidence. A direct trial in adults with obesity without diabetes found greater average weight reduction with tirzepatide over 72 weeks. That result does not establish which medication an individual will tolerate better or should take. Treatment selection belongs with a licensed clinician. SURMOUNT-5 trial.

Quick Overview: Key Differences

Question	Tirzepatide	Semaglutide
Which receptors does it activate?	GIP and GLP-1	GLP-1
Which approved weight-management products are discussed here?	Zepbound	Wegovy
What did the direct injection trial report?	20.2% average weight reduction at week 72	13.7% average weight reduction at week 72
Which is easier to tolerate?	Individual response varies	Individual response varies
Where can I check Boca program prices?	Tirzepatide plans	Semaglutide plans

The table’s weight results come from the same trial, not a comparison assembled from unrelated studies. They concern the products and doses studied, not compounded preparations. Mechanism and product details: Zepbound prescribing information and Wegovy prescribing information.

What the Direct Comparison Found

SURMOUNT-5 was a randomized, open-label trial involving 751 adults with obesity without type 2 diabetes. Participants received maximum tolerated weekly injection doses of tirzepatide (10 or 15 mg) or semaglutide (1.7 or 2.4 mg) for 72 weeks. These are study conditions, not a dosing recommendation.

Average weight reduction was 20.2% with tirzepatide and 13.7% with semaglutide. Gastrointestinal events were the most common adverse events in both groups. Eli Lilly funded the study. The open-label design and defined population matter when interpreting the findings. Individual outcomes vary. Read the original trial report.

Why separate trial percentages can mislead

STEP 1 studied semaglutide against placebo; SURMOUNT-1 studied tirzepatide against placebo. Differences in participants, study duration, dose, and outcome definitions limit comparisons across those studies. Their results should not be used as a simple ranking of which drug causes fewer side effects. STEP 1, SURMOUNT-1.

Side Effects and Important Warnings

Nausea, vomiting, diarrhea, constipation, and abdominal symptoms can occur with these medicines. Discuss persistent or severe symptoms with your clinician. A population average cannot predict your experience, and tolerability should not be inferred from the weight-loss result alone.

The approved products carry boxed warnings about thyroid C-cell tumors observed in rodents; whether this occurs in humans is unknown. They are contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2. Important risks also include pancreatitis, gallbladder problems, severe gastrointestinal reactions, dehydration-related kidney injury, and serious allergic reactions. This is not an exhaustive safety list. Read the current product information with your clinician. Zepbound warnings, Wegovy warnings.

Seek urgent medical care for severe, persistent abdominal pain. Get emergency help for trouble breathing or swelling of the face or throat. Discuss pregnancy plans and all other medicines with your prescriber before treatment. Follow the instructions for the exact product prescribed; do not use an online comparison to select, increase, switch, or convert doses.

For additional background, see managing semaglutide side effects and managing tirzepatide side effects.

Compounded Products Are a Separate Question

Compounded semaglutide and tirzepatide are not FDA-approved. FDA does not review their safety, effectiveness, or quality before marketing. They are not FDA-approved generics, and results from trials of approved products do not demonstrate the effectiveness or safety of a compounded preparation. Compounding should address a patient’s medical need that an approved drug cannot meet; a lower price alone does not establish that need. FDA compounding questions and answers.

Learn more about compounded semaglutide safety and compounded tirzepatide safety. Your clinician and dispensing pharmacist can explain the particular formulation and instructions.

Cost and Access

Compare the exact product, pharmacy, insurance benefits, and current manufacturer savings terms. An introductory offer may differ from the ongoing price. A monthly equivalent on a prepaid plan is different from a monthly-billed price. Include required consultations, membership, supplies, shipping, and any commitment in your budget.

Boca’s current semaglutide plans, tirzepatide plans, and pricing page identify its compounded programs and their terms. Check state availability and provider information before enrolling. Price comparisons do not establish clinical equivalence.

Questions to Discuss With Your Clinician

• Which exact product is appropriate for my medical history and treatment goals?
• How do its approved uses, contraindications, and warnings apply to me?
• How will we monitor response and side effects?
• What should I do if I cannot tolerate treatment or cannot obtain a refill?
• What will the ongoing cost be after any introductory period?

Frequently Asked Questions

Is tirzepatide better than semaglutide?

The direct trial favored tirzepatide for average weight reduction in its study population. That is not a universal treatment recommendation. Medical history, tolerability, approved indications, access, and individual response all matter.

Does semaglutide cause fewer side effects?

This article does not establish that ranking. Both medicines can cause gastrointestinal effects and have important warnings. Discuss your own risk factors and prior medication experience with a clinician.

Can I switch or convert my dose myself?

No. The products are not interchangeable on a milligram-for-milligram basis. Ask your prescriber for product-specific instructions rather than using a comparison table to change treatment.

Do these trial results apply to compounded medication?

No clinical equivalence is established by these trials. Compounded preparations were not the products tested and are not FDA-approved.

Medical disclaimer: This article is educational and does not replace individualized medical advice. Consult a licensed clinician about treatment. Individual results vary and are not guaranteed.